A description is given of a new microprocessor-based device for EEG analysis. The Cerebral Function Analysing Monitor (CFAM) analyses the EEG amplitude and frequency dittribution. It produces a detailed plot of amplitude trends and separate traces of the percentage activity in each of the classical EEG frequency bands. Its clinical application was studied in five patients anaesthetized with thiopentone, and nitrous oxide and halothane in oxygen. During maintenance of anaesthesia, there was a gradual decrease in EEG amplitude and shift towards lower frequency EEG activity. Discontinuation of nitrous oxide resulted in a marked increase in EEG amplitude and an increase in alpha and beta band activity. Discontinuation of halothane resulted in smaller alterations in the CFAM trace. This device provides easily interpreted processed EEG data and merits further investigation.
Since 1929 when Berger successfully recorded the EEG in man, attempts have been made to characterize the EEG responses to anaesthetic agents (Berger, 1929) . Courtin, Bickford and Faukoner (1950) produced a detailed scale of EEG levels of anaesthesia for volatile agents, and Brazier and Finesinger (1945) described the EEG effects of barbiturates. The classification of EEG changes relating to anaesthetic depth led to attempts to achieve servocontrol of anaesthesia (Bickford, 1949; Verzeano, 1951) . Later, data reduction techniques using graphic plots for assessment by the anaesthetist were explored. Perhaps the best known of these is the compressed spectral array (CS A) described by Bickford, Fleming and Billinger (1971) , which analysed successive epochs of the EEG using a Fast Fourier Transformation (FFT).
Various alternative methods of analysis have been proposed and some of these have been reviewed by Levy and colleagues (1980) . The Cerebral Function Monitor (CFM) as described by Maynard, Prior and Scott (1969) , was intended to warn of EEG trends of gross neurological significance (Prior, 1979) , but has also been used during i.v. anaesthesia (Dubois et al., 1978; Frank et al., 1982) . The CFM produces, on slow-moving paper, a display of the variations in EEG amplitude, as seen through an asymmetric bandpass filter. However, small alterations in the EEG, such as occur during light anaesthesia, are not indicated clearly because they are often associated with changes in frequency content as opposed to amplitude.
We describe here a new apparatus which combines the benefits of detailed amplitude analysis and display with frequency analysis using a modified zero-crossing technique. The use of this device in spontaneously breathing patients during general anaesthesia has been assessed.
APPARATUS
The Cerebral Function Analysing Monitor (CFAM, Health Care Developments Ltd, Stevenage) was designed by one of the authors (D.E.M.) and is a 6808 microprocessor-based development of the CFM (Maynard, 1979) .
Before analysis the EEG signal is passed through an asymmetric bandpass filter (1.5-27 Hz) which, over the range 2-22 Hz, gives increased amplification with increase in frequency at a rate of 12dB per decade. This weighting compensates for the attenuation of the EEG with increase of frequency, such that at times when no sinusoidal activity is presentobtained from either channel. It is also possible to write out two-channel EEG samples. The amplitude is plotted on a logarithmic scale and consists of the 10th centile, the mean and the 90th centile of the amplitude distribution, the plots being smoothed retrospectively over approximately 20 s and written every 2 s. Additionally, within each 2-s epoch the absolute maximum and minimum amplitudes are plotted if they lie above or below the upper and lower centiles, respectively. The lowest voltage plotted is equivalent to a 0.63 \i V peak-to-peak sine wave at 10 Hz ( fig. 1) .
Frequency analysis is performed on the weighted signal by a modified zero crossing technique in which low frequencies are analysed separately. Frequency content is plotted as the percentage of total activity in each of the frequency bands: beta (13-27 Hz), alpha (7.5-13 Hz), theta (3.5-7.5 Hz) and delta (1 -3.5 Hz). Percentage values of frequency were chosen so that alterations in EEG amplitude would not affect the frequency distribution. These are plotted every 2 s and smoothed retrospectively over approximately 20 s. Frequency analysis ran be performed on signals as low as one uV peak-to-peak.
Large amplitude waves below 1 Hz (VLF, very low frequency), are plotted when they penetrate the bandpass filter. These occur from a variety of causes including psycho-galvanic responses, mechanical artefacts, low frequency EEG and eye movements.
Low amplitude EEG may occur during deep anaesthesia, drug overdose, profound hypothermia or other states characterized by deep coma. The CFAM plots the percentage time that the weighted EEG amplitude is below a preset value, which can be set by the user from 1 to 5nV. Muscle activity, electrode impedance and amount of line frequency interference are plotted also. The muscle activity plot is necessary because the spectrum of scalp muscle potentials overlaps that of the EEG and can contribute significantly to it. Since the muscle content cannot be removed by filtering, it is indicated when present at frequencies greater than those of the EEG (200-1000 Hz).
Movements of the electrodes produce changes of impedance and artefactual voltages which may interfere with the EEG. The impedance is monitored by a 200-Hz sine wave applied across the recording electrodes via 10-MCI resistors. After amplification the signal is separated from other data by means of a narrow band filter. Line interference at the recording electrodes is not desirable since it can interfere with the computation of evoked potentials. It may on occasion also warn of the malfunction of other equipment. The CFAM measures this interference by means of synchronous detectors. Using external stimulators the CFAM can compute evoked potentials on two input channels, simultaneously with the amplitude and frequency analysis. Sweep lengths of 500, 250, 125, 15 and 10 ms are provided. The amplitude and frequency analysis plot is interrupted for about 6 s to write out the evoked potentials.
The output of the CFAM may be transmitted in digital form via an RS 232 C interface to a suitable computer. On line analysis, data storage or control of the CFAM operation may be carried out using a remote computer.
CLINICAL STUDY

Patients and methods
Five female patients (mean age 38 yr) undergoing breast surgery gave informed consent for the study. Approval was obtained from the local Ethics Committee. Diazepam 10 mg was used for premedication. On arrival in the operating theatre two biparietal and one frontal (reference) CFAM needle electrodes were inserted subcutaneously after spraying the skin with ethyl chloride. Induction of anaesthesia was with sufficient thiopentone to obtund the eyelash reflex. In two patients tracheal intubation was performed following the administration of suxamethonium, and 4% lignocaine spray. Anaesthesia was maintained with 67% nitrous oxide and halothane (2% inspired) in oxygen, all patients breathing spontaneously via a Magill circuit. At the end of surgery nitrous oxide was discontinued and when the CFAM trace was again stable (5-10min later) halothane was discontinued and the tracheal tube removed (two patients). Recovery of consciousness was allowed to occur spontaneously: that is, the patient was not deliberately stimulated in any manner.
RESULTS
Induction of anaesthesia with thiopentone caused an increase in weighted EEG amplitude in all patients lasting from 3 to 13min. Examples are shown in figures 2 and 3. This was accompanied in four patients by a short-lasting decrease in higher frequency activity (beta) and an increase in theta and delta activity. In one patient ( fig. 3) , induction of anaesthesia was accompanied by a transient increase in higher frequency activity (beta) and decreases in the other frequency bands.
In four patients, deepening halothane anaesthesia was associated with a gradual decrease in weighted EEG amplitude. This was accompanied by an increase in the proportion of delta-and theta-band 100 T
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B 10 "5. activity with consequent decreases in alpha and beta. In one patient the amplitude remained relatively constant with beta-band activity in excess of 20%. When nitrous oxide was discontinued there was an immediate steep increase in the amplitude trace in all patients ( fig. 4 ). This was accompanied by increasing activity in the higher frequency bands. When halothane was discontinued some minutes later, relatively small changes occurred in the CFAM traces. However, in two patients, beta-band activity increased and in three patients, EMG artefact preceeded the return of consciousness. It should be emphasized that no attempts were made to stimulate or rouse the patients and that consciousness was allowed to return spontaneously.
DISCUSSION
The original CFM has been used in varying situations including cardiopulmonary bypass, hypotensive anaesthesia, i.v. anaesthesia, carotid endarterectomy and in the intensive therapy unit (Prior, 1979) . It has been criticized (Levy et al., 1980) because small trends are obscured and no frequency information is given. The CFAM provides detailed frequency and amplitude analysis every 2 s and is, therefore, likely to be of more value in assessing less marked trends. In addition, the CFAM has the ability to compute evoked potentials simultaneously with conducting EEG frequency and amplitude analysis and this facility should enhance its clinical and research applications. The stimulators for evoked potentials were not available during the study, so this facility was not tested clinically. Signals entering the CFAM for amplitude and frequency analysis are passed first through the asymmetric filter, which gives increased amplification to the higher EEG frequencies. This is used because higher frequency EEG signals are of much lower voltage than lower frequency signals. Therefore, the CFAM gives increased emphasis to betaband activity and decreased emphasis to delta when compared with the unprocessed EEG. Thus, the CFAM trace should not be considered a direct representation of the power contained in the various frequency bands, especially as the frequency analysis is displayed as a percentage of the filtered activity. If filtering is not carried out, then EEG signals with a high delta component will tend to swamp the display at the expense of other signals (Sebel et al., 1981) . The CFAM trace is designed to show changes in frequency and amplitude distribution in the clearest manner possible rather than to represent the EEG as it would be recorded by a conventional machine.
Our choice of anaesthetic technique may be criticized in that we have used a combination of several agents which are known to affect the EEG, thus making interpretation of the traces difficult. However, we felt it important to make the initial evaluation of the apparatus in a common clinical situation, particularly since the original cerebral function monitor did not provide a clear indication of anaesthetic depth in patients anaesthetized with a similar technique. In this preliminary study marked changes of frequency content occurred with little change in weighted signal amplitude and demonstrate the advantage of frequency analysis. On induction of anaesthesia four patients showed a response to thiopentone characterized by an increase in amplitude and a short-lasting decrease in high frequency activity. A shift to delta frequencies has been shown to be associated with surgical anaesthesia (Sebel et al., 1981) . In one patient ( fig. 3) there was no discernible decrease in beta activity during induction, possibly indicating that the thiopentone dose was inadequate. Small doses of thiopentone are known to cause an increase in beta-band activity (Stockard and Bickford, 1975) . The shift in amplitude related to thiopentone lasted for 3-13 min (figs 2,3) whereas the frequency changes lasted for approximately 5 min, which is in keeping with the clinical duration of action of thiopentone. As the effect of thiopentone wore off, an increase of beta activity occurred in all patients. The frequency analysis may provide a useful indicator of the adequacy of the dose of thiopentone.
Maintenance of anaesthesia with halothane was characterized by decreases in amplitude and high frequency activity. It may be that in most patients a marked decrease of beta-band activity in the CFAM trace indicates that anaesthesia with halothane is "deep". Unfortunately, in one patient this shift was not seen. Either this patient was inadequately anaesthetized, although this was not evident clinically, or this was an atypical response. Further data are required to elucidate this point.
Nitrous oxide and halothane were discontinued separately to assess the effects of each agent. Discontinuation of nitrous oxide caused marked alterations in CFAM trace, an increase in amplitude and a shift to higher frequencies. Work currently in progress in our unit suggests that this increase in amplitude is indeed related to discontinuation of nitrous oxide, rather than some combined effect of the two agents.
In conclusion, the CFAM provides useful, easily interpreted EEG information. The availability of stimulators will allow the recording of multimodali-ty evoked potentials and enhance the applications of this instrument. Consistent CFAM changes were found during thiopentone-halothane-nitrous oxide anaesthesia and the device is worthy of further investigation.
